Forasartan, a specific angiotensin II antagonist, is used alone or with other antihypertensive agents to treat hypertension. Forasartan competes with angiotensin II for binding at the AT1 receptor subtype. As angiotensin II is a vasoconstrictor which also stimulates the synthesis and release of aldosterone, blockage of its effects results in a decreases in systemic vascular resistance.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Aliskiren | The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Forasartan. |
| Canagliflozin | The risk or severity of hypotension, hyperkalemia, and reduced intravascular volume can be increased when Canagliflozin is combined with Forasartan. |
| Drospirenone | The risk or severity of hyperkalemia can be increased when Forasartan is combined with Drospirenone. |
| Eplerenone | The risk or severity of hyperkalemia can be increased when Eplerenone is combined with Forasartan. |
| Semuloparin | The risk or severity of hyperkalemia can be increased when Semuloparin is combined with Forasartan. |
| Methyclothiazide | Methyclothiazide may increase the hypotensive and Electrolyte Disturbance activities of Forasartan. |
| Bendroflumethiazide | Bendroflumethiazide may increase the hypotensive and Electrolyte Disturbance activities of Forasartan. |
| Benzthiazide | Benzthiazide may increase the hypotensive and Electrolyte Disturbance activities of Forasartan. |
| Cyclothiazide | Cyclothiazide may increase the hypotensive and Electrolyte Disturbance activities of Forasartan. |
| Hydroflumethiazide | Hydroflumethiazide may increase the hypotensive and Electrolyte Disturbance activities of Forasartan. |
| Chlorothiazide | Chlorothiazide may increase the hypotensive and Electrolyte Disturbance activities of Forasartan. |
| Hydrochlorothiazide | Hydrochlorothiazide may increase the hypotensive and Electrolyte Disturbance activities of Forasartan. |
| Trichlormethiazide | Trichlormethiazide may increase the hypotensive and Electrolyte Disturbance activities of Forasartan. |
| Polythiazide | Polythiazide may increase the hypotensive and Electrolyte Disturbance activities of Forasartan. |
| Mebutizide | Mebutizide may increase the hypotensive and Electrolyte Disturbance activities of Forasartan. |
| Cyclopenthiazide | Cyclopenthiazide may increase the hypotensive and Electrolyte Disturbance activities of Forasartan. |
| Buthiazide | Buthiazide may increase the hypotensive and Electrolyte Disturbance activities of Forasartan. |
| Lithium citrate | The serum concentration of Lithium citrate can be increased when it is combined with Forasartan. |
| Lithium carbonate | The serum concentration of Lithium carbonate can be increased when it is combined with Forasartan. |
| Lithium hydroxide | The serum concentration of Lithium hydroxide can be increased when it is combined with Forasartan. |
| Tolvaptan | The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Forasartan. |
| Trimethoprim | The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Forasartan. |
| Ciprofloxacin | The risk or severity of hyperkalemia can be increased when Forasartan is combined with Ciprofloxacin. |
| Cyclosporine | The risk or severity of hyperkalemia can be increased when Forasartan is combined with Cyclosporine. |
| Nicorandil | The risk or severity of hyperkalemia can be increased when Nicorandil is combined with Forasartan. |
| Icosapent | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Icosapent. |
| Mesalazine | The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Forasartan. |
| Indomethacin | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Indomethacin. |
| Nabumetone | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Nabumetone. |
| Tenoxicam | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Tenoxicam. |
| Celecoxib | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Celecoxib. |
| Tolmetin | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Tolmetin. |
| Rofecoxib | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Rofecoxib. |
| Piroxicam | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Piroxicam. |
| Fenoprofen | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Fenoprofen. |
| Valdecoxib | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Valdecoxib. |
| Diclofenac | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Diclofenac. |
| Sulindac | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Sulindac. |
| Flurbiprofen | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Flurbiprofen. |
| Etodolac | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Etodolac. |
| Mefenamic acid | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Mefenamic acid. |
| Naproxen | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Naproxen. |
| Sulfasalazine | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Sulfasalazine. |
| Phenylbutazone | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Phenylbutazone. |
| Meloxicam | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Meloxicam. |
| Carprofen | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Carprofen. |
| Diflunisal | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Diflunisal. |
| Salicylic acid | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Salicylic acid. |
| Meclofenamic acid | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Meclofenamic acid. |
| Acetylsalicylic acid | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Acetylsalicylic acid. |
| Oxaprozin | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Oxaprozin. |
| Ketoprofen | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Ketoprofen. |
| Balsalazide | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Balsalazide. |
| Ibuprofen | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Ibuprofen. |
| Lumiracoxib | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Lumiracoxib. |
| Magnesium salicylate | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Magnesium salicylate. |
| Salsalate | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Salsalate. |
| Choline magnesium trisalicylate | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Choline magnesium trisalicylate. |
| Antrafenine | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Antrafenine. |
| Aminophenazone | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Aminophenazone. |
| Antipyrine | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Antipyrine. |
| Tiaprofenic acid | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Tiaprofenic acid. |
| Etoricoxib | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Etoricoxib. |
| Taxifolin | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Taxifolin. |
| Oxyphenbutazone | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Oxyphenbutazone. |
| Licofelone | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Licofelone. |
| Nimesulide | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Nimesulide. |
| Benoxaprofen | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Benoxaprofen. |
| Metamizole | The risk or severity of hyperkalemia can be increased when Forasartan is combined with Metamizole. |
| Zomepirac | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Zomepirac. |
| Cimicoxib | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Cimicoxib. |
| Lornoxicam | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Lornoxicam. |
| Aceclofenac | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Aceclofenac. |
| Zaltoprofen | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Zaltoprofen. |
| Azapropazone | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Azapropazone. |
| Parecoxib | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Parecoxib. |
| Salicylamide | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Salicylamide. |
| Kebuzone | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Kebuzone. |
| Isoxicam | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Isoxicam. |
| Indoprofen | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Indoprofen. |
| Ibuproxam | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Ibuproxam. |
| Floctafenine | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Floctafenine. |
| Fenbufen | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Fenbufen. |
| Etofenamate | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Etofenamate. |
| Epirizole | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Epirizole. |
| Benzydamine | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Benzydamine. |
| Dexibuprofen | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Dexibuprofen. |
| Dexketoprofen | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Dexketoprofen. |
| Droxicam | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Droxicam. |
| Tolfenamic acid | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Tolfenamic acid. |
| Firocoxib | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Firocoxib. |
| Clonixin | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Clonixin. |
| Morniflumate | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Morniflumate. |
| Propacetamol | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Propacetamol. |
| Talniflumate | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Talniflumate. |
| Robenacoxib | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Robenacoxib. |
| Tepoxalin | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Tepoxalin. |
| Flunixin | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Flunixin. |
| Polmacoxib | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Polmacoxib. |
| Nitroaspirin | The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Nitroaspirin. |